Neokimia Inc., of Sherbrooke, Quebec, appointed Robert Déziel senior director, research...ProdiGene Inc., of College Station, Texas, said its CEO and president, Anthony Laos, was appointed by President George W. Bush to serve as a member of the Board for International Food and Agriculture Development

Advancis Pharmaceutical Corp., of Gaithersburg, Md., added Robert Guttendorf as vice president of preclinical research and Beth Burnside as senior director of formulation development...Ixion Biotechnology Inc., of Alachua, Fla., added Albert Fosmoe as senior manager, regulatory affairs and quality assurance, and Chris Setina and Marlo Tan Walpole to its oxalate control product program

Syrrx Inc., of San Diego, added Jeffrey Stafford as senior director of chemistry and Daniel Kassel as senior director of analytical technologies

Aderis Pharmaceuticals Inc., of Hopkinton, Mass., appointed Todd Brady senior director of business development and named Joseph Bianchine to its board...Laurence McCarthy, former president and CEO, will become chairman and chief technology officer

Achillion Pharmaceuticals Inc., of New Haven, Conn., added John Pottage as senior director, drug development...ARC Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Michael Diamond and Victor Gomel to its scientific advisory board...Atrix Laboratories Inc., of Fort Collins, Colo., added Tony Zhang as senior director of marketing

CytoGenix Inc., of Houston, elected Scott Parazynski and Frank Vazquez to its board...Genomics Collaborative Inc., of Cambridge, Mass., promoted Kevin Krenitsky to senior vice president and medical director and named Roberto Rodriguez senior director of business development, genomics

and Lioudmila Tchistiakova as section head, microbiology and genomics...and named John Prunty treasurer and assistant corporate secretary

Structural Bioinformatics Inc., of San Diego, added Robert Ingersoll as senior director, national sales...Trigen Ltd., of London, appointed Tony Kennedy vice president, development, and Oliver Boucher vice president, commercial development

EpiCept Corp., of Englewood Cliffs, N.J., added Howard Maibach and Misha-Miroslav Backonja to its board of scientific and medical advisers...Protarga Inc., of King of Prussia, Pa., appointed Frank Bambarola vice president, oncology, and Timothy McKinlay senior director, clinical operations

ExonHit Therapeutics SA, of Paris, appointed Christina Hedberg senior director, business development, working in its U.S...NimbleGen Systems Inc., of Madison, Wis., appointed Steven Smith vice president, bioinformatics and Albrecht Frauendorf senior director, DNA array manufacturing

Ceregene Inc., of San Diego, added Dominick Vacante as senior director of product development and Brooks Ensign as director of business development...and Robert Tenerowicz to vice president, process development and clinical supplies

Inhibitex Inc., of Atlanta, appointed James Barrett and Douglas Eplett to its board...OSI Pharmaceuticals Inc., of Melville, N.Y., added Gary Clark as senior director of biostatistics and data management...Senetek plc, of Napa, Calif., added Franklin Pass and Wade Nichols to its board

aaiPharma Inc., of Wilmington, N.C., named Philip Tabbiner president and chief operating officer and named David Hurley president of NeoSan Pharmaceuticals...Microbia Inc., of Cambridge, Mass., added Richard Bailey as senior director, biomanufacturing business development

Serologicals Corp., of Atlanta, said its CEO and president, David Dodd, was elected chairman of the Georgia Biomedical Partnership...VaxGen Inc., of Brisbane, Calif., named Carmen Betancourt vice president of regulatory affairs and quality assurance and Mark Busch senior director of quality assurance

Introgen also appointed Janet Gregory senior director of clinical development, Keith Coffee director of clinical sciences and Bruce Ross director of clinical operations...and Kevin Kaster to senior vice president, legal affairs

Advanced Neuromodulation Systems Inc., of Dallas, named Kenneth Hawari general counsel and executive vice president, corporate development...Anadys Pharmaceuticals Inc., of San Diego, appointed David Kramer chief financial officer, Elizabeth Reed director of legal affairs, Brad Kerr senior director of clinical affairs and Wei Liaw associate director of pharmaceutical development...Cambrex Corp., of East Rutherford, N.J., appointed Daniel Marshak vice president and chief technology officer

RxKinetix Inc., of Louisville, Colo., named John Carpenter, Mark Manning and Ted Randolph to its scientific advisory board...appointed Donald Brown senior director of marketing for Viacord

AtheroGenics Inc., of Atlanta, promoted Charles Deignan to senior director of finance and administration...Metabolex Inc., of Hayward, Calif., appointed John Blume vice president of strategic technologies and added Gary Titus as senior director of finance

Diversa Corp., of San Diego, appointed Lisa Moss senior director of pharmaceutical business development, Mick Noordewier senior director of bioinformatics, Bruce Kimmel director of protein therapeutics and Geoffrey Hazlewood director of industrial enzyme products...Also, the company promoted Mervyn Bibb to senior director, small molecule discovery, and Mike Lafferty to director, engineering technology